00:00It's Benzinga, bringing Wall Street to Main Street.
00:02Eli Lilly reported first quarter earnings and revenue above estimates
00:06and raised its full year sales outlook by $2 billion
00:09as demand for Zep Bound and Monjaro increased, according to CNBC.
00:14Eli Lilly reported adjusted earnings of $8.55 per share on $19.80 billion in revenue,
00:21beating Wall Street estimates of $6.66 per share and $17.62 billion.
00:27The company raised its 2026 revenue outlook to $82 billion to $85 billion
00:33from $80 billion to $83 billion.
00:37Eli Lilly increased adjusted profit guidance to $35.50 to $37 per share
00:43from $33.50 to $35.
00:46Demand for Zep Bound and Monjaro drove results as Monjaro revenue rose 125%
00:52to $8.66 billion.
00:54And Zep Bound U.S. sales reached $4.16 billion.
01:00Net income rose to $7.40 billion from $2.76 billion.
01:06U.S. revenue climbed 43% to $12.1 billion.
01:11Shares rose more than 5% in pre-market trading on Thursday.
01:15For all things money, visit Benzinga.com.
01:17Bound U.S.��
01:17company fell to $16. situação at . Once
01:18we've got $33. We're
01:18And we're right.
Comments